Latest Amyotrophic lateral sclerosis Stories
GERMANTOWN, Md., Jan. 6, 2015 /PRNewswire/ -- Neuralstem, Inc.
NEW YORK and PETACH TIKVAH, Israel, Jan. 5, 2014 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc.
A new study published in Proceedings of the National Academy of Sciences has found that a drug used to treat Lou Gehrig’s disease (ALS) called riluzole can prevent cognitive decline in lab rats, and could lead to effective treatments in humans.
Safety and efficacy findings from interim analysis to be extended with additional data and analyses NEW YORK and PETACH TIKVAH, Israel, Dec.
Gene therapy pioneer and longtime Veterans Affairs researcher Dr. David Fink received the 2014 Paul B. Magnuson Award from VA in a ceremony at the VA Ann Arbor Healthcare System on Dec.
Major League Baseball’s Commitment to Fighting ALS and The ALS Ice Bucket Challenge Spurs Funding. WASHINGTON/CHICAGO, (PRWEB) December 03, 2014 The
Company Continues to Expect Clinical Trial Timelines to Remain Materially Unchanged and Expeditiously Resolved LOS ANGELES, Dec.
LOS ANGELES, Dec.
NETBANX Makes Unprecedented Online Donations Possible MONTREAL, Nov.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.